Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04556045 · ClinicalTrials.gov registry record · NA
Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer
A NA study of Malignant Neoplasm of Prostate, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT04556045 is a NA study of Malignant Neoplasm of Prostate that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04556045, a NA study of Malignant Neoplasm of Prostate, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to determine if patients receiving personalized exercise therapy (versus those who do not receive personalized exercise therapy) have improved quality of life and physical functioning after completing their radiation therapy. Second, the study is being done to find if the quality of life changes during therapy correlate with measurements of inflammation in the blood. Third, the study is being done to see if adding exercise therapy to radiation therapy will improve survival.
Conditions Studied
Interventions
- BEHAVIORAL Exercise therapy
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-12-11 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04556045
The ClinicalTrials.gov registry entry for NCT04556045 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Neoplasm of Prostate appearing as the primary indexed condition, and to 1 intervention - of which Exercise therapy is the first listed.
NCT04556045 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04556045 about?
NCT04556045 is a clinical study titled "Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer". This study is being done to determine if patients receiving personalized exercise therapy (versus those who do not receive personalized exercise therapy) have improved quality of life and physical functioning after completing their radiation therapy. Second, the study is being done to find if the qu...
What is the current status of trial NCT04556045?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-12-11. Estimated completion is 2026-12.
What conditions does trial NCT04556045 study?
This clinical trial studies the following conditions: Malignant Neoplasm of Prostate.
What interventions are being tested in trial NCT04556045?
The interventions under investigation include: Exercise therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04556045?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04556045 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm of Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.